Evofem Strengthens SOLOSEC Intellectual Property with New U.S. Patent from USPTO
February 14, 2025
Evofem Biosciences, announced that the United States Patent and Trademark Office (USPTO) issued to the Company a Notice of Allowance for patent application 17/028,838, entitled